Literature DB >> 20583411

Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection.

Noritaka Wakui1, Kazunari Iida, Takashi Ikehara, Ryuji Takayama, Kazue Shiozawa, Masayoshi Takahashi, Hidenari Nagai, Manabu Watanabe, Koji Ishii, Yoshinori Igarashi, Yasukiyo Sumino.   

Abstract

BACKGROUND/AIMS: The incidence of local recurrence of hypervascular hepatocellular carcinoma (HCC) (15 mm or less) was compared retrospectively between a group treated with radiofrequency ablation (RFA) using cool-tip (Radionics, USA) 10-mm electrodes and a group treated with percutaneous ethanol injection (PEI).
METHODOLOGY: There were 23 patients who were treated for a total of 25 tumors during a 3-year period at our hospital. Ten of the tumors (11.1 +/- 2.7mm) were treated with RFA using cool-tip 10-mm electrodes and 15 tumors (10.6 +/- 2.7 mm) were treated with PEI. After treatment, progression was evaluated in enhanced CT scans every 3-6 months to confirm presence or absence of local recurrence.
RESULTS: The number of recurrences, mean observation period, and mean recurrence period in the RFA group were 2 (20%), 6.6 months, and 6 months. The number of recurrences, mean observation period, and mean recurrence period in the PEI group were 2 (13.3%), 19.1 months, and 18 months. The period between treatment and recurrence tended to be longer in the PEI group than in the RFA group to be significant p < 0.05.
CONCLUSIONS: The results suggest that PEI treatment is more effective in local treatment of hypervascular HCC with tumor diameters of 15 mm or less.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583411

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience.

Authors:  Koray Karabulut; Federico Aucejo; Hizir Yakup Akyildiz; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

2.  Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case-control comparative analysis.

Authors:  Su Jong Yu; Jung-Hwan Yoon; Jeong Min Lee; Jae Young Lee; Se Hyung Kim; Young Youn Cho; Jeong-Ju Yoo; Minjong Lee; Dong Hyeon Lee; Yuri Cho; Eun Ju Cho; Jeong-Hoon Lee; Yoon Jun Kim; Chung Yong Kim
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 3.  Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis.

Authors:  Wen Luo; Yunfei Zhang; Guangbin He; Ming Yu; Minjuan Zheng; Liwen Liu; Xiaodong Zhou
Journal:  World J Surg Oncol       Date:  2017-07-10       Impact factor: 2.754

4.  Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols.

Authors:  Takahashi Masayoshi; Noritaka Wakui; Yasukiyo Sumino
Journal:  Exp Ther Med       Date:  2012-09-13       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.